BSEGODAVARI DRUGS LTD.LowNeutral
Announced Sat, 26 Sept, 2026 · 17:57 IST

Godavari Drugs 38th AGM: all 4 resolutions passed, plans entry into nutraceuticals

Board & Shareholder Meetings View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-6.2%1-day move
₹128.50
prior close
₹127.21
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.4+1.4+1.4-1.7-6.2-5.8-7.4-9.6-9.5+0.5————
Up moveDown movePending
AI summary

Godavari Drugs held its 38th AGM on September 25, 2026 via video conferencing. All 4 resolutions passed with 99.96 percent votes in favour (only 1,570 votes against out of 43.37 lakh polled). Items included adoption of FY26 financial statements, reappointment of director Mr Ghanshyam Jaju, and ratification of cost auditor remuneration. The special resolution approved adding nutraceuticals, dietary supplements, health supplements, herbal extracts and functional foods as a new main object, signalling business expansion into health and wellness products.

Likely market impact

Shareholders approved expansion into nutraceuticals and wellness products. All resolutions passed with over 99.96 percent majority, showing strong shareholder support.